Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot

Recruiting N/A Interventional Study
Hepatitis B Hepatitis C AIDS
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
500 (estimated)
Sponsor
University Hospital, Rouen · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Former or active intravenous and/or nasal drug user * Person on opiate substitution therapy Exclusion Criteria: * Person with known active viral infection(s)
Contacts

Ghassan RIACHI, MD

+3323288

ghassan.riachi@chu-rouen.fr

CONTACT

Julien BLOT

+3323288

julien.blot@chu-rouen.fr

CONTACT